[Fe<sup>III</sup>Cl(TMPPH<sub>2</sub>)][Fe<sup>III</sup>Cl<sub>4</sub>]<sub>2</sub>: A Stand-Alone Molecular Nanomedicine that Induces High Cytotoxicity by Ferroptosis DOI Open Access
Xiao Wang,

Jiahao Feng,

Chunmei Zeng

и другие.

Опубликована: Апрель 29, 2024

Developing clinically meaningful nanomedicines for cancer therapy requires the drugs to be effective, safe, simple, cheap, and easy store. In present work, we report that a simple cationic Fe(III)-rich salt of [FeIIICl(TMPPH2)][FeIIICl4]2 (Fe-TMPP) exhibits superior anticancer performance toward broad spectrum cell lines, including breast, colorectal cancer, liver, pancreatic, prostate, gastric cancers, with half maximal inhibitory concentration (IC50) values in range 0.098−3.97 μM (0.066−2.68 μg mL−1), comparable best-reported medicines. Fe-TMPP can forms stand-alone nanoparticles water without need extra surface modification or organic-solvent-assisted antisolvent precipitation. Critically, is TME-responsive (TME = tumor microenvironment), only elicit its function TME overexpressed H2O2, converting H2O2 cytotoxic •OH oxidize phospholipid membrane, causing ferroptosis, programmed death process cells.

Язык: Английский

Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications DOI Creative Commons
Ying Liu, Wei‐Qun Ding, Jianxun Wang

и другие.

Frontiers in Oncology, Год журнала: 2023, Номер 13

Опубликована: Сен. 8, 2023

Lung cancer (LC) is a heterogeneous disease with high malignant degree, rapid growth, and early metastasis. The clinical outcomes of LC patients are generally poor due to the insufficient elucidation pathological mechanisms, low efficiency detection assessment methods, lack individualized therapeutic strategies. Non-coding RNAs (ncRNAs), including microRNA (miRNA), long non-coding RNA (lncRNA), circular (circRNA), endogenous regulators that widely involved in modulation almost all aspects life activities, from organogenesis aging immunity cancer. They commonly play vital roles various biological processes by regulating gene expression via their interactions DNA, RNA, or protein. An increasing amount studies have demonstrated ncRNAs closely correlated initiation development LC. Their dysregulation promotes progression distinct such as influencing protein activity, activating oncogenic signaling pathways, altering specific expression. Furthermore, some present certain values biomarker candidates targets for patients. A complete understanding mechanisms may be highly beneficial developing ncRNA-based therapeutics This review mainly focuses on intricate miRNA, lncRNA, circRNA discuss underlying applications treatment.

Язык: Английский

Процитировано

44

Recent Progress on Second Near-Infrared Emitting Carbon Dots in Biomedicine DOI
Mei Yang,

Yongqi Han,

Alberto Bianco

и другие.

ACS Nano, Год журнала: 2024, Номер 18(18), С. 11560 - 11572

Опубликована: Апрель 29, 2024

Second near-infrared (NIR-II) carbon dots, with absorption or emission between 1000 and 1700 nm, are gaining increasing attention in the biomaterial field due to their distinctive properties, which include straightforward preparation processes, stable photophysical characteristics, excellent biocompatibility, low cost. As a result, there is growing focus on controlled synthesis modulation of photochemical properties NIR-II aim further expand biomedical applications, current research hotspot. This account aims provide comprehensive overview recent advancements dots within field. The review will cover following topics: (i) design, synthesis, purification (ii) surface modification strategies, (iii) particularly domain cancer theranostics. Additionally, this addresses challenges encountered by outline future directions realm By exploring carbon-based biomaterials, we can anticipate that contribution garner increased contribute development next-generation advanced functional thereby offering enhanced tools strategies

Язык: Английский

Процитировано

16

Dumbbell-shaped bimetallic AuPd nanoenzymes for NIR-II cascade catalysis-photothermal synergistic therapy DOI Open Access
Zhe Tang,

Yike Hou,

Shuqi Huang

и другие.

Acta Biomaterialia, Год журнала: 2024, Номер 177, С. 431 - 443

Опубликована: Фев. 2, 2024

Язык: Английский

Процитировано

10

Nanomaterial-based regulation of redox metabolism for enhancing cancer therapy DOI

Xiaodan Jia,

Yue Wang, Yue Qiao

и другие.

Chemical Society Reviews, Год журнала: 2024, Номер unknown

Опубликована: Янв. 1, 2024

This review provides a comprehensive summary of the dysregulation redox metabolism in cancer cells and advantages latest advances nanomaterial-assisted metabolic regulation therapy.

Язык: Английский

Процитировано

7

The Application of Nanovaccines in Autoimmune Diseases DOI Creative Commons
Yuhong Tang, Lili Li

International Journal of Nanomedicine, Год журнала: 2024, Номер Volume 19, С. 367 - 388

Опубликована: Янв. 1, 2024

Abstract: Autoimmune diseases are caused by the body's chronic immune responses to self-antigens and attacks on host's own cells, tissues organs. The dysfunction of innate immunity adaptive leads destruction autoimmune tolerance, which is most basic factor leading pathogenesis. optimal strategy for modify host system restore tolerance. ideal effect therapeutic eliminate autoantigen-specific spontaneous response without interfering with against other antigens. Therapeutic nanovaccines that produce tolerance conform this principle. Nanomaterials provide a platform antigen loading modification due their unique physical chemical properties. Nanovaccines based nanomaterial technology can simultaneously enable antigens adjuvants be absorbed cells induce rapid durable immunity. have advantages being able designed loaded better protecting from premature degradation. also ability target specific or through optimized design. We review latest research progress design strategies promote development more effective diseases. Keywords: nanovaccines, diseases,

Язык: Английский

Процитировано

6

Nanozyme-based cancer theranostics: A scientometric analysis and comprehensive review DOI
Xing Yang, Feroza Yasinjan,

Shuhao Sun

и другие.

Nano Today, Год журнала: 2024, Номер 57, С. 102386 - 102386

Опубликована: Июль 13, 2024

Язык: Английский

Процитировано

6

A Cardiac‐Targeting and Anchoring Bimetallic Cluster Nanozyme Alleviates Chemotherapy‐Induced Cardiac Ferroptosis and PANoptosis DOI Creative Commons
Junyue Xing, Xiaohan Ma,

Yanan Yu

и другие.

Advanced Science, Год журнала: 2024, Номер unknown

Опубликована: Окт. 28, 2024

Abstract Doxorubicin (DOX), a potent antineoplastic agent, is commonly associated with cardiotoxicity, necessitating the development of strategies to reduce its adverse effects on cardiac function. Previous research has demonstrated strong correlation between DOX‐induced cardiotoxicity and activation oxidative stress pathways. This work introduces novel antioxidant therapeutic approach, utilizing libraries tannic acid N‐acetyl‐L‐cysteine‐protected bimetallic cluster nanozymes. Through extensive screening for antioxidative enzyme‐like activity, an optimal nanozyme (AuRu) identified that possess remarkable characteristics, mimicking catalase‐like enzymes. Theoretical calculations reveal surface interactions prepared nanozymes simulate hydrogen peroxide decomposition process, showing these readily undergo OH⁻ adsorption O₂ desorption. To enhance targeting, atrial natriuretic peptide conjugated AuRu nanozyme. These cardiac‐targeted nanozymes, their anchoring capability, effectively cardiomyocyte ferroptosis PANoptosis without compromising tumor treatment efficacy. Thus, approach demonstrates significant reductions in chemotherapy‐induced cell death improvements function, accompanied by exceptional vivo biocompatibility stability. study presents promising avenue preventing offering potential clinical benefits cancer patients.

Язык: Английский

Процитировано

6

Patterned Au@Ag nanoarrays with electrically stimulated laccase-mimicking activity for dual-mode detection of epinephrine DOI

Anni Cui,

Jialü Zhang, Zhifei Liu

и другие.

Talanta, Год журнала: 2024, Номер 272, С. 125821 - 125821

Опубликована: Фев. 22, 2024

Язык: Английский

Процитировано

5

A Cu‐Based Single‐Atom Nanozyme Platform with Multi‐Enzyme Simulated Activities for Immunotherapy of Prostate Cancer by Regulating Cholesterol Metabolism and Triggering Pyroptosis DOI
Bo Xu, Rui Niu, Ruiping Deng

и другие.

Advanced Functional Materials, Год журнала: 2024, Номер 34(46)

Опубликована: Июнь 10, 2024

Abstract Immunotherapy, one of the most promising antitumor strategies, is used to treat prostate cancer (PCa). However, owing immunosuppressive tumor microenvironment (TME), therapeutic effect immune response greatly weakened. Therefore, there an urgent need explore new methods enhance responses. In this study, a single‐atom nanozyme platform (Cu SA‐DOX@COD) that can trigger pyroptosis developed activate responses via gasdermin E (GSDME)‐dependent pathway. It triggered by catalyzing production reactive oxygen species (ROS) and depleting reduced glutathione through intrinsic multi‐enzyme simulated activities providing source for cholesterol (CHOL) oxidation. Meanwhile, loaded CHOL oxidase not only reduces content cells increase cell membrane permeability inhibit proliferation invasion but also oxidizes increases level H 2 O in pyroptosis. addition, doxorubicin activated caspase‐3 cleave GSDME further augment Consequently, Cu SA‐DOX@COD enhances immunocompetence reshapes TME triggering caused ROS storm, chemotherapy, CHOL, thereby activating systemic immunity PCa.

Язык: Английский

Процитировано

5

Opportunities and trends in therapeutics application of nanozymes DOI

Sarthak Bansal,

Akanksha Deshwal, Prashant Sharma

и другие.

Elsevier eBooks, Год журнала: 2024, Номер unknown, С. 139 - 156

Опубликована: Янв. 1, 2024

Язык: Английский

Процитировано

4